Home Cart Sign in  
Chemical Structure| 78281-02-4 Chemical Structure| 78281-02-4

Structure of Hydroxysafflor yellow A
CAS No.: 78281-02-4

Chemical Structure| 78281-02-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Hydroxysafflor yellow A is a flavonoid derived and isolated from traditional Chinese medicine Carthamus tinctorius L., possessing anti-tumor activity.

Synonyms: Safflomin A; HSYA

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Hydroxysafflor yellow A

CAS No. :78281-02-4
Formula : C27H32O16
M.W : 612.53
SMILES Code : OC(C(O)=C1C(/C=C/C2=CC=C(O)C=C2)=O)([C@]([C@@H]([C@@H](O)[C@@H]3O)O)([H])O[C@@H]3CO)C(O)=C([C@@H]([C@@H]([C@@H](O)[C@@H]4O)O)O[C@@H]4CO)C1=O
Synonyms :
Safflomin A; HSYA
MDL No. :MFCD08435942

Safety of Hydroxysafflor yellow A

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H319-H317
Precautionary Statements:P305+P351+P338-P280

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Rat aortic endothelial cells (RAECs) 7.5 μmol/L 24 and 48 hours To evaluate the effects of hydroxysafflor yellow A on the production of coagulation-associated factors by LPS-stimulated endothelial cells. Results showed that hydroxysafflor yellow A significantly reduced the production of sTM and TF and increased the production of TFPI. Acta Pharmacol Sin. 2024 May;45(5):1077-1092
Rat peritoneal macrophages 7.5 μmol/L 24 and 48 hours To evaluate the effects of hydroxysafflor yellow A on the production of pro-inflammatory cytokines by LPS-stimulated macrophages. Results showed that hydroxysafflor yellow A significantly inhibited the production of TNF-α, IL-6, IL-1β, and HMGB1. Acta Pharmacol Sin. 2024 May;45(5):1077-1092
Rat splenic regulatory T cells (Tregs) 7.5 μmol/L 72 hours To evaluate the effects of hydroxysafflor yellow A on the function and apoptosis of LPS-stimulated Tregs. Results showed that hydroxysafflor yellow A significantly reduced the expression levels of CTLA-4 and FOXP3, decreased IL-10 secretion, and increased the apoptosis rate of Tregs. Acta Pharmacol Sin. 2024 May;45(5):1077-1092
Co-culture of human endometrial perivascular stem cells (En-PSCs) with HUVECs 50 μM HSYA 3 hours Assess synergistic effects of En-PSCs/HSYA on angiogenesis, demonstrating enhanced tube formation and branching points. Stem Cell Res Ther. 2024 Jul 18;15(1):217
Human umbilical vein endothelial cells (HUVECs) 50 μM 3 hours Evaluate the effect of HSYA on angiogenesis in HUVECs, showing significantly increased tube formation. Stem Cell Res Ther. 2024 Jul 18;15(1):217

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats Cecal ligation and puncture (CLP)-induced sepsis model Intravenous injection 4 mL/kg Administered at 2, 12, 24, 36, 48, and 60 h after surgery, for 7 days To evaluate the effects of hydroxysafflor yellow A on immune regulation, inflammation inhibition, coagulation modulation, and protection against multiple organ dysfunction in CLP rats. Results showed that hydroxysafflor yellow A significantly reduced the expression levels of CTLA-4 and FOXP3, decreased IL-10 secretion, increased the apoptosis rate of Tregs, inhibited the production of pro-inflammatory cytokines, modulated coagulation status, and improved multiple organ function. Additionally, hydroxysafflor yellow A significantly increased the survival rate of CLP rats. Acta Pharmacol Sin. 2024 May;45(5):1077-1092
Sprague-Dawley rats Spinal cord compression injury model Intraperitoneal injection 8 mg/kg (at 1 and 6 h after injury), then 14 mg/kg for 7 days Once at 1 and 6 h after injury, then once daily for 7 days HSYA treatment significantly reduced tissue injury, oxidative stress, inflammatory response, and neuronal apoptosis, and improved limb functional recovery after spinal cord injury. J Neuroinflammation. 2017 May 3;14(1):97
Zebrafish TPEN-induced hematopoietic defect model Aqueous solution immersion 100 μg/mL Single treatment, lasting 12 hours To evaluate the protective effects of HSYA on TPEN-induced hematopoietic defects in zebrafish. Results showed that HSYA significantly restored the number of HSCs and inhibited the P53 signaling pathway and oxidative stress. MedComm (2020). 2023 Aug 24;4(5):e352
Mice Oleic acid-induced acute lung injury model 15 mg/kg Activation of anti-oxidant enzymes and inactivation of the inflammatory response via the cAMP/PKA pathway Pharmacol Res. 2021 Jan;163:105224

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.63mL

0.33mL

0.16mL

8.16mL

1.63mL

0.82mL

16.33mL

3.27mL

1.63mL

References

 

Historical Records

Categories